Katerina Akassoglou information

This biography of a living person relies too much on references to primary sources. Please help by adding secondary or tertiary sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately, especially if potentially libelous or harmful. Find sources: "Katerina Akassoglou" – news · newspapers · books · scholar · JSTOR (May 2020) (Learn how and when to remove this message)

Katerina Akassoglou
Akassoglou in 2019
Born	1972 (age 51–52) Athens, Greece
Nationality	Greek, American
Alma mater	University of Athens, The Rockefeller University, New York University Skirball Institute of Biomolecular Medicine
Known for	Role of fibrin in CNS inflammation and neurodegeneration
Awards	Presidential Early Career Award for Scientists and Engineers, John J. Abel Award in Pharmacology, Barancik Prize for Innovation in MS Research
Scientific career
Fields	Neuroimmunology, hematology
Institutions	University of California, San Francisco

Katerina Akassoglou is a neuroimmunologist who is a Senior Investigator and Director of In Vivo Imaging Research at the Gladstone Institutes. Akassoglou holds faculty positions as a Professor of Neurology at the University of California, San Francisco. Akassoglou has pioneered investigations of blood-brain barrier integrity and development of neurological diseases. She found that compromised blood-brain barrier integrity leads to fibrinogen leakage into the brain inducing neurodegeneration. Akassoglou is internationally recognized for her scientific discoveries.